Literature DB >> 8865526

Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.

F Violl1, S Basili, D Ferro, C Quintarelli, C Alessandril, C Cordova.   

Abstract

Cirrhotic patients with decompensated state and high serum levels of fibrin(ogen) degradation products are at high risk of bleeding. The aim of this study was to further analyse the relationship between hyperfibrinolysis and bleeding in cirrhosis by measuring plasma values of D-dimer and tissue plasminogen activator (t-PA) activity. One-hundred-twelve cirrhotic patients with oesophageal varices and without previous upper-gastrointestinal bleeding entered the study and were followed-up for 3 years. Patients were considered to have hyperfibrinolysis if they concomitantly had high values of D-dimer and t-PA activity. During the follow-up 34 (30%) patients bled. They had more severe liver failure (p = 0.0001) and variceal size (p = 0.0031) and higher prevalence of ascites (p = 0.0003), varices with red signs and hyperfibrinolysis (p = 0.0001) than patients who did not bleed. Multivariate analysis disclosed hyperfibrinolysis as the only marker predictive of bleeding (Hazard Ratio = 42.5, p < 0.001). Our findings suggest that screening for hyperfibrinolysis may be useful to identify cirrhotic patients at risk of bleeding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865526

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Coagulopathy of Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 2.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.

Authors:  M Saliola; R Lorenzet; D Ferro; S Basili; C Caroselli; A D Santo; M Sallese; F Violi
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

4.  Hyperfibrinolysis.

Authors:  B J Hunt; H Segal
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.

Authors:  Nikita Joshi; Anna K Kopec; Keara Towery; Kurt J Williams; James P Luyendyk
Journal:  J Pharmacol Exp Ther       Date:  2014-03-14       Impact factor: 4.030

6.  Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Authors:  Francesca Romana Ponziani; Valerio De Stefano; Antonio Gasbarrini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-30       Impact factor: 2.576

7.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

8.  Comparison of Thromboelastography and Conventional Coagulation Tests in Patients With Severe Liver Disease.

Authors:  Patryck Lloyd-Donald; Abhinav Vasudevan; Peter Angus; Paul Gow; Johan Mårtensson; Neil Glassford; Glenn M Eastwood; Graeme K Hart; Daryl Jones; Laurence Weinberg; Rinaldo Bellomo
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 9.  Bleeding Disorders in Primary Fibrinolysis.

Authors:  Massimo Franchini; Marco Zaffanello; Pier Mannuccio Mannucci
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

10.  Prediction model of emergency mortality risk in patients with acute upper gastrointestinal bleeding: a retrospective study.

Authors:  Lan Chen; Han Zheng; Saibin Wang
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.